Skip to main content

CITADEL ADVISORS LLC

Position in ENVB — Enveric Biosciences, Inc.

CIK 1423053 MIAMI, FL

Position in ENVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,271
+$4,783 QoQ
Shares Held
13,965
+639.3% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 24 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENVB Over Time

Shares Held

Position Value (USD)

Derivatives in ENVB

reported options exposure · as of Jun 30, 2022
CallValue
$7,746
CallShares
0
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ENVB ranks #416 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENVB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,271 13,965
2025-09-30 $14,488 22,674
2025-03-31 $27,883 20,060
2024-12-31 $5,376 15,017
2024-09-30 $6,044 12,753
2024-03-31 $40,104 40,104
2023-06-30 $46,954 13,933
2022-06-30 $7,746 36,200
2022-03-31 $70,883 214,800
2022-03-31 $10,262 31,100
2022-03-31 $19,249 58,332
2021-12-31 $293,972 316,100
2021-12-31 $144,277 155,137
2021-12-31 $42,593 45,800
2021-09-30 $179,362 86,649
2021-09-30 $109,088 52,700
2021-09-30 $540,062 260,900
2021-06-30 $31,142 13,085
2020-12-31 $60,378 10,199